Caxton Associates
Caxton Associates LP is a $7.6 billion New York-based hedge fund, founded in 1983 by Bruce Kovner.
Caxton Associates' primary business is to manage client and proprietary capital through global macro hedge fund strategies as well as other alternative investment disciplines.
Caxton employs over 205 people at its offices in New York, Princeton, NJ and London.
View Older Stories View More Recent Stories
-
Form SC 13G Cardiff Oncology, Inc. Filed by: CAXTON CORP
-
Cardiff Oncology (CRDF) Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
-
Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
-
UPDATE - CalciMedica Appoints Robert N. Wilson as Co-Chairman of the Board of Directors and Eric W. Roberts as Vice Chairman
-
CalciMedica Robert N. Wilson, Former J&J Vice Chairman as Co-Chairman of the Board of Directors and Eric W. Roberts as Vice Chairman
-
Form 13F-HR CAXTON ASSOCIATES LP For: Mar 31
-
Form 13F-HR CAXTON CORP For: Mar 31
-
Form D/A Caxton Dynamis (USA)
-
Bridgewater hedge funds post mixed results amid market turmoil
-
Form 13F-HR CAXTON ASSOCIATES LP For: Dec 31
-
Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: CAXTON CORP
-
Form SC 13G/A Alcentra Capital Corp Filed by: CAXTON CORP
-
Form SC 13G/A Garrison Capital Inc. Filed by: CAXTON CORP
-
Form SC 13G/A SCYNEXIS INC Filed by: CAXTON CORP
-
Form SC 13G/A Satsuma Pharmaceuticals, Filed by: CAXTON CORP
-
Form SC 13G/A Investcorp Credit Manage Filed by: CAXTON CORP
-
Form 13F-HR CAXTON CORP For: Dec 31
-
Form SC 13G Sierra Oncology, Inc. Filed by: CAXTON CORP
-
Makor Capital Hires Ian Epstein as New President of Its U.S. Global Macro Division
-
MRMP-Managers LLC and Barnwell Industries’ Largest Independent Shareholder Group, Sends Letter to Shareholders
-
Form 4 Molecular Templates, For: Nov 21 Filed by: CAXTON CORP
-
Form 13F-HR CAXTON ASSOCIATES LP For: Sep 30
-
Form 13F-HR CAXTON CORP For: Sep 30
-
Kirby Corp. (KEX) Announces Tanya S. Beder to Board
-
Kirby Corporation Announces New Director of the Board Tanya S. Beder
-
Kirby Corporation Announces New Director of the Board Tanya S. Beder
-
Form SC 13G Satsuma Pharmaceuticals, Filed by: CAXTON CORP
-
Caxton: Manual Expense Reporting Costs UK PLCs £2.8bn in Lost Productivity Every Year
-
Liberated Syndication Announces Settlement Agreement with Camac Partners
-
Cinctive Capital Management Launches with $1 Billion in Investor Commitments
-
Form D Caxton Advantage (USA)
-
Form D/A Caxton Macro (USA) LLC
-
Form 13F-HR CAXTON ASSOCIATES LP For: Jun 30
-
Form 13F-HR CAXTON CORP For: Jun 30
-
Form D/A Caxton Global Investment
-
Form SC 13G SUNESIS PHARMACEUTICALS Filed by: CAXTON CORP
-
Blackstone Hires Gabriel Sod Hoffs as New Head of Emerging Markets and Global Macro Strategies
-
Blackstone hires Caxton manager for global macro, emerging markets
-
Form 13F-HR CAXTON ASSOCIATES LP For: Mar 31
-
Form 13F-HR CAXTON CORP For: Mar 31
-
Camac Initiates Process to Call for Special Meeting of Stockholders of Liberated Syndication
-
Form D Caxton Dynamis (USA)
-
CalciMedica Names Life Science Veteran to its Board of Directors
-
Form SC 13G/A CM Finance Inc Filed by: CAXTON CORP
-
Form SC 13G/A SCYNEXIS INC Filed by: CAXTON CORP
-
Form SC 13G/A MEI Pharma, Inc. Filed by: CAXTON CORP
-
Form SC 13G/A Garrison Capital Inc. Filed by: CAXTON CORP
-
Form 13F-HR CAXTON ASSOCIATES LP For: Dec 31
-
Form 13F-HR CAXTON CORP For: Dec 31
-
Form SC 13G Alcentra Capital Corp Filed by: CAXTON CORP

